Loading…
Calcium signaling in cancer progression and therapy
The old Greek aphorism ‘Panta Rhei’ (‘everything flows’) is true for all living things in general. As a dynamic process, calcium signaling plays fundamental roles in cellular activities under both normal and pathological conditions, with recent researches uncovering its involvement in cell prolifera...
Saved in:
Published in: | The FEBS journal 2021-11, Vol.288 (21), p.6187-6205 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The old Greek aphorism ‘Panta Rhei’ (‘everything flows’) is true for all living things in general. As a dynamic process, calcium signaling plays fundamental roles in cellular activities under both normal and pathological conditions, with recent researches uncovering its involvement in cell proliferation, migration, survival, gene expression, and more. The major question we address here is how calcium signaling affects cancer progression and whether it could be targeted to combine with classic chemotherapeutics or emerging immunotherapies to improve their efficacy.
Calcium signaling is broadly involved in cancer progression as its abnormal activation promotes malignant behaviors of cancer cells, contributes to various oncogenes and oncogenic pathways, and mediates suppression of immune response. Therefore, targeting calcium signaling is potential for the development of novel anticancer therapies. A calcium signaling‐based agent may be a cancer cell killer, a chemo‐sensitizer and an immunotherapy enhancer. |
---|---|
ISSN: | 1742-464X 1742-4658 |
DOI: | 10.1111/febs.16133 |